Ginna Laport
Directeur Technique/Scientifique/R&D chez CARGO THERAPEUTICS, INC.
Fortune : - $ au 30/04/2024
Profil
Ginna G.
Laport is currently the Chief Medical Officer at Cargo Therapeutics, Inc. She previously held positions as the National Chairman at Blood & Marrow Transplant Clinical Trials Network, Vice President-Clinical Development at Genentech, Inc., Vice President-Clinical Development at Corvus Pharmaceuticals, Inc., Assistant Professor at the University of Pennsylvania, and Professor at Stanford University School of Medicine.
She also served as the Chief Medical Officer at Tempest Therapeutics, Inc. Dr. Laport completed her undergraduate degree at Baylor University and her doctorate at The University of Texas at Austin.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CARGO THERAPEUTICS, INC.
-.--% | 05/04/2024 | 0 ( -.--% ) | - $ | 30/04/2024 |
Postes actifs de Ginna Laport
| Sociétés | Poste | Début |
|---|---|---|
| CARGO THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 17/10/2023 |
Anciens postes connus de Ginna Laport
| Sociétés | Poste | Fin |
|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Directeur Technique/Scientifique/R&D | 01/10/2023 |
| TEMPEST THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/10/2019 |
| CORVUS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/09/2018 |
| Stanford University School of Medicine | Corporate Officer/Principal | 01/10/2015 |
| University of Pennsylvania | Corporate Officer/Principal | 01/01/2001 |
Formation de Ginna Laport
| Baylor University | Undergraduate Degree |
| The University of Texas at Austin | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| CORVUS PHARMACEUTICALS, INC. | Health Technology |
| TEMPEST THERAPEUTICS, INC. | Health Technology |
| CARGO THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
| Blood & Marrow Transplant Clinical Trials Network |